Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Common Equity (2020 - 2025)

Incannex Healthcare's Common Equity history spans 5 years, with the latest figure at $73.4 million for Q4 2025.

  • For Q4 2025, Common Equity rose 7514.73% year-over-year to $73.4 million; the TTM value through Dec 2025 reached $73.4 million, up 7514.73%, while the annual FY2025 figure was $13.4 million, 19.36% up from the prior year.
  • Common Equity for Q4 2025 was $73.4 million at Incannex Healthcare, down from $77.0 million in the prior quarter.
  • Across five years, Common Equity topped out at $77.0 million in Q3 2025 and bottomed at $964000.0 in Q4 2024.
  • The 4-year median for Common Equity is $13.4 million (2025), against an average of $22.9 million.
  • The largest annual shift saw Common Equity tumbled 94.89% in 2024 before it skyrocketed 7514.73% in 2025.
  • A 4-year view of Common Equity shows it stood at $8.6 million in 2021, then skyrocketed by 120.11% to $18.9 million in 2023, then crashed by 94.89% to $964000.0 in 2024, then surged by 7514.73% to $73.4 million in 2025.
  • Per Business Quant, the three most recent readings for IXHL's Common Equity are $73.4 million (Q4 2025), $77.0 million (Q3 2025), and $13.4 million (Q2 2025).